<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34922826</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2212-4411</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Oral surgery, oral medicine, oral pathology and oral radiology</Title><ISOAbbreviation>Oral Surg Oral Med Oral Pathol Oral Radiol</ISOAbbreviation></Journal><ArticleTitle>Long-COVID and the practice of oral medicine.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>128</EndPage><MedlinePgn>125-128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.oooo.2021.10.025</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2212-4403(21)00724-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patton</LastName><ForeName>Lauren L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Division of Craniofacial and Surgical Care, Adams School of Dentistry, University of North Carolina at Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oral Surg Oral Med Oral Pathol Oral Radiol</MedlineTA><NlmUniqueID>101576782</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009909" MajorTopicYN="N">Oral Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019242" MajorTopicYN="Y">Oral Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>19</Day><Hour>20</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34922826</ArticleId><ArticleId IdType="pmc">PMC8571099</ArticleId><ArticleId IdType="doi">10.1016/j.oooo.2021.10.025</ArticleId><ArticleId IdType="pii">S2212-4403(21)00724-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cecchini MP, Brozzetti L, Cardobi N, et al. Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset [e-pub ahead of print]. Neurol Sci.https://doi:10.1007/s10072-021-05635-y. accessed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05635-y</ArticleId><ArticleId IdType="pmc">PMC8487402</ArticleId><ArticleId IdType="pubmed">34601698</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Post-COVID conditions. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Flong-term-effects.html. Accessed October 23, 2021.</Citation></Reference><Reference><Citation>United States Department of Health and Human Services. Office of Civil Rights. Guidance on &#x201c;Long COVID&#x201d; as a disability under the ADA, Section 504, and Section 1557. Available at: https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disability/index.html#footnote10_0ac8mdc. Accessed October 23, 2021.</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed October 23, 2021.</Citation></Reference><Reference><Citation>National Institutes of Health  . 2021. 2021. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid Available at. Accessed October 23.</Citation></Reference><Reference><Citation>Jones R, Davis A, Stanley B, et al. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmat Obs Res. 2021;12:93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, et al. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021;19:249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Teaima AA, Salem OM, Teama MAEM, et al. Patterns and clinical outcomes of olfactory and gustatory disorders in six months: prospective study of 1031 COVID-19 patients. Am J Otolaryngol. https://doi:10.1016/j.amjoto.2021.103259, accessed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103259</ArticleId><ArticleId IdType="pmc">PMC8481118</ArticleId><ArticleId IdType="pubmed">34626912</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Cheng V, Manoharan L, et al. What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review. F1000Res. 2020;9:1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459620</ArticleId><ArticleId IdType="pubmed">34621523</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study [e-pub ahead of print]. Lancet Infect Dis. https://doi:10.1016/S1473-3099(21)00460-6, accessed .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafloo R, Majidi J, Asghari A, et al. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021;12:3795&#x2013;3805.</Citation><ArticleIdList><ArticleId IdType="pubmed">34609841</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani E, Khiali S, Beheshtirouy S, Entezari-Maleki T. Potential pharmacologic treatments for COVID-19 smell and taste loss: a comprehensive review [e-pub ahead of print]. Eur J Pharmacol. https://doi:10.1016/j.ejphar.2021.174582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174582</ArticleId><ArticleId IdType="pmc">PMC8524700</ArticleId><ArticleId IdType="pubmed">34678243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabot AB, Huntwork MP. Turmeric as a possible treatment for COVID-19-induced anosmia and ageusia. Cureus. 2021;13:e17829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8502749</ArticleId><ArticleId IdType="pubmed">34660038</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . 2021. 2021. https://covid19.who.int Accessed October 27. Accessed October 27.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>